Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Prepaid Assets: 2014-2024

Historic Prepaid Assets for KalVista Pharmaceuticals (KALV) over the last 6 years, with Dec 2024 value amounting to $6.2 million.

  • KalVista Pharmaceuticals' Prepaid Assets was N/A to $6.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.2 million, marking a year-over-year change of. This contributed to the annual value of $6.8 million for FY2024, which is N/A change from last year.
  • As of Q4 2024, KalVista Pharmaceuticals' Prepaid Assets stood at $6.2 million, which was up 14.94% from $5.4 million recorded in Q4 2024.
  • Over the past 5 years, KalVista Pharmaceuticals' Prepaid Assets peaked at $7.5 million during Q3 2023, and registered a low of $1.5 million during Q4 2020.
  • In the last 2 years, KalVista Pharmaceuticals' Prepaid Assets had a median value of $6.2 million in 2024 and averaged $6.3 million.
  • Examining YoY changes over the last 5 years, KalVista Pharmaceuticals' Prepaid Assets showed a top increase of 30.26% in 2020 and a maximum decrease of 42.03% in 2020.
  • KalVista Pharmaceuticals' Prepaid Assets (Quarterly) stood at $1.5 million in 2020, then grew by 26.76% to $4.6 million in 2021, then reached $5.5 million in 2023, then declined by 0.90% to $6.2 million in 2024.
  • Its last three reported values are $6.2 million in Q4 2024, $5.4 million for Q4 2024, and $7.5 million during Q3 2024.